Real fears remain about the impact on the NHS of a 'no deal' Brexit
16 October 2020
Commenting on the potential impact of a 'no deal' Brexit on the NHS, NHS Providers deputy chief executive Saffron Cordery said:
“Our fears about a 'no deal' Brexit remain.
“The NHS relies on robust arrangements being in place with the European Union (EU). These includes ensuring that EU staff can continue to work for the NHS, medicines and equipment supplies from the EU are not negatively impacted and there are reciprocal arrangements in place.
“The NHS is currently recovering services following the first wave of the pandemic, managing the second wave and preparing for the additional burdens of winter. Now, we are asking the same staff to put in place arrangements for the NHS following a 'no deal' Brexit.
“It’s vital that trusts are sighted on any potential disruption so that they can prepare effectively, particularly as the stakes are so high. They need as much information as possible, as early as possible.
“We saw problems with supplies during the first wave of COVID, for example of anaesthesia drugs because of high levels of ventilation. Going into a second surge, securing respiratory drugs is a particular priority. A 'no deal' Brexit could disrupt the main supply routes for drugs through Europe to the UK.”